相似文献
1
Neuromuscular Involvement in COVID-19 Patients.
Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):768-769. doi: 10.4103/aian.AIAN_565_20. Epub 2021 Mar 24.
2
Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.
Rev Neurol (Paris). 2020 Jun;176(6):507-515. doi: 10.1016/j.neurol.2020.04.004. Epub 2020 Apr 20.
3
COVID-19 Neuromuscular Involvement in Post-Acute Rehabilitation.
Brain Sci. 2021 Dec 6;11(12):1611. doi: 10.3390/brainsci11121611.
4
COVID-19 in children with neuromuscular disorders.
J Neurol. 2021 Sep;268(9):3081-3085. doi: 10.1007/s00415-020-10339-y. Epub 2021 Jan 2.
5
A Comprehensive Review of Neuromuscular Manifestations of COVID-19 and Management of Pre-Existing Neuromuscular Disorders in Children.
J Clin Med. 2022 Feb 11;11(4):934. doi: 10.3390/jcm11040934.
6
Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.
Neurol Sci. 2021 Jun;42(6):2173-2178. doi: 10.1007/s10072-021-05110-8. Epub 2021 Mar 23.
7
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase.
Acta Myol. 2020 Jun 1;39(2):57-66. doi: 10.36185/2532-1900-008. eCollection 2020 Jun.
8
COVID-19 and neuromuscular disorders.
Neurology. 2020 Jun 2;94(22):959-969. doi: 10.1212/WNL.0000000000009566. Epub 2020 Apr 13.
9
Neuromuscular complications of severe COVID-19 in paediatric patients: Medium-term follow-up.
Neuromuscul Disord. 2022 Jun;32(6):486-492. doi: 10.1016/j.nmd.2022.04.001. Epub 2022 Apr 9.
10
Clinical impact of COVID-19 on Turkish children with neurological and neuromuscular diseases: One center experience.
Medicine (Baltimore). 2021 Dec 23;100(51):e28401. doi: 10.1097/MD.0000000000028401.
本文引用的文献
1
COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
J Med Virol. 2021 Jan;93(1):66-68. doi: 10.1002/jmv.26121. Epub 2020 Jun 12.
2
Olfactory and Gustatory Dysfunction in a COVID-19 Patient with Ankylosing Spondylitis Treated with Etanercept: Case Report.
J Korean Med Sci. 2020 Jun 1;35(21):e201. doi: 10.3346/jkms.2020.35.e201.
3
Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.
Ear Nose Throat J. 2020 Nov;99(9):579-583. doi: 10.1177/0145561320929169. Epub 2020 May 29.
4
Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis.
Ann Rheum Dis. 2020 Oct;79(10):1383-1386. doi: 10.1136/annrheumdis-2020-217522. Epub 2020 May 22.
5
Pulmonary and systemic involvement in COVID-19 patients assessed with ultrasound-guided minimally invasive autopsy.
Histopathology. 2020 Aug;77(2):186-197. doi: 10.1111/his.14160. Epub 2020 Jul 24.
6
COVID 19: Neuromuscular Manifestations.
Ann Indian Acad Neurol. 2020 Apr;23(Suppl 1):S40-S42. doi: 10.4103/aian.AIAN_309_20. Epub 2020 Apr 21.
7
Myasthenic crisis in COVID-19.
J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.
8
Myositis as a manifestation of SARS-CoV-2.
Ann Rheum Dis. 2021 Mar;80(3):e42. doi: 10.1136/annrheumdis-2020-217573. Epub 2020 Apr 23.
9
Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients.
J Med Virol. 2020 Oct;92(10):1793-1794. doi: 10.1002/jmv.25903. Epub 2020 Jun 2.
10
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
Zotero 插件